GelIta-Health-Initiative.com
Title
GELITA Health Initiative
Description
The GELITA Health Initiative: supports innovative therapy in osteoarthritis
The GELITA Health Initiative was established by the GELITA Group, the developer of CH-Alpha, a product containing an optimized collagen hydrolysate that stimulates cartilage regeneration. The GHI’s objective is to intensively promote collagen hydrolysate research in the area of degenerative joint disease and disseminate this information to physicians, pharmacists, nutritional scientists and patients.
Scientists have been researching the positive effects of collagen hydrolysate on the cartilage matrix for some twenty years. The results obtained from studies have shown that collagen hydrolysate helps maintain healthy joint cartilage and considerably accelerates its regeneration when subjected to excessive stress.
Recent results from laboratory studies have shown that collagen hydrolysate stimulates chondrocyte metabolism and increases cartilage collagen synthesis by a factor of 2.5. Recent clinical studies indicate that patients who take collagen hydrolysate experience improved joint mobility and decreased subjective pain intensity.
Logos
